Literature DB >> 12193655

Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Sheila A Stewart1, William C Hahn, Benjamin F O'Connor, Elisa N Banner, Ante S Lundberg, Poonam Modha, Hana Mizuno, Mary W Brooks, Mark Fleming, Drazen B Zimonjic, Nicholas C Popescu, Robert A Weinberg.   

Abstract

Once immortalized, human cells are susceptible to transformation by introduction of an oncogene such as ras. Several lines of evidence now suggest that the maintenance of telomere length is a major determinant of replicative lifespan in human cells and thus of the immortalized state. The majority of human tumor cells acquire immortality through expression of the catalytic subunit of telomerase (hTERT), whereas others activate an alternative mechanism of telomere maintenance (ALT) that does not depend on the actions of telomerase. We have examined whether ALT could substitute for telomerase in the processes of transformation in vitro and tumorigenesis in vivo. Expression of oncogenic H-Ras in the immortal ALT cell line GM847 did not result in their transformation. However, subsequent ectopic expression of hTERT in these cells imparted a tumorigenic phenotype. Indeed, this outcome was also observed after introduction of a mutant hTERT that retained catalytic activity but was incapable of maintaining telomere length. These studies indicate that hTERT confers an additional function that is required for tumorigenesis but does not depend on its ability to maintain telomeres.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193655      PMCID: PMC130507          DOI: 10.1073/pnas.182407599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Resistance to apoptosis in human cells conferred by telomerase function and telomere stability.

Authors:  S E Holt; V V Glinsky; A B Ivanova; G V Glinsky
Journal:  Mol Carcinog       Date:  1999-08       Impact factor: 4.784

2.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

3.  Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment.

Authors:  C Kuperwasser; J Pinkas; G D Hurlbut; S P Naber; D J Jerry
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

4.  Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes.

Authors:  L Van Parijs; Y Refaeli; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

5.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

6.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

Authors:  X Zhang; V Mar; W Zhou; L Harrington; M O Robinson
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

7.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

8.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

9.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.

Authors:  T R Yeager; A A Neumann; A Englezou; L I Huschtscha; J R Noble; R R Reddel
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

10.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.

Authors:  H Vaziri; S Benchimol
Journal:  Curr Biol       Date:  1998-02-26       Impact factor: 10.834

View more
  136 in total

1.  Telomerase extracurricular activities.

Authors:  Sandy Chang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  The labeling efficiency of human telomeres is increased by double-strand PRINS.

Authors:  Ju Yan; Bing-Zhen Chen; Eric F Bouchard; Régen Drouin
Journal:  Chromosoma       Date:  2004-09-02       Impact factor: 4.316

3.  Separation of telomerase functions by reverse genetics.

Authors:  Shibani Mukherjee; Eduardo J Firpo; Yang Wang; James M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 4.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

5.  hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.

Authors:  M J Choi; K H Cho; S Lee; Y J Bae; K J Jeong; S Y Rha; E J Choi; J H Park; J M Kim; J-S Lee; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

6.  Small circular DNAs for synthesis of the human telomere repeat: varied sizes, structures and telomere-encoding activities.

Authors:  Jörg S Hartig; Eric T Kool
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

7.  Telomerase can act as a template- and RNA-independent terminal transferase.

Authors:  Neal F Lue; Dimitry Bosoy; Tara J Moriarty; Chantal Autexier; Brian Altman; Siyang Leng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

8.  No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells.

Authors:  Natalie Erdmann; Lea A Harrington
Journal:  DNA Repair (Amst)       Date:  2008-12-25

9.  Involvement of telomerase reverse transcriptase in heterochromatin maintenance.

Authors:  Yoshiko Maida; Mami Yasukawa; Naoko Okamoto; Seii Ohka; Keita Kinoshita; Yasushi Totoki; Takashi K Ito; Tohru Minamino; Hiromi Nakamura; Satoko Yamaguchi; Tatsuhiro Shibata; Kenkichi Masutomi
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

Review 10.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.